Skip to main content

Advertisement

Log in

Sympathetic ophthalmia after surgical resection of iridociliary melanoma. A case report

  • Case Report
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

We report a case of sympathetic ophthalmia with systemic findings following resection of a malignant melanoma of the iris and ciliary body, and describe the treatment and clinical outcome.

Methods

A 49-year-old man underwent sector iridocyclectomy of a malignant iridociliary melanoma of the right eye. Five weeks later, he was diagnosed with sympathetic ophthalmia. Snellen’s best-corrected visual acuity, fluorescein angiography, electroretinography, cerebrospinal fluid analysis and audiometry were performed. High-dose systemic steroid and immunosuppressive (cyclosporine and azathioprine) therapy was prescribed. Two months later chorioretinitis and macular edema persisted, and intravitreous triamcinolone was injected into the right eye.

Results

Five weeks after resection of an iridociliary melanoma, our patient had reported acute bilateral vision loss. Visual acuity was hand motion in both eyes. Examination showed bilateral granulomatous uveitis, diffuse choroiditis with Dalen-Fuchs nodules, papillitis and vitritis. On fluorescein angiography multiple hyperfluorescent dots, which coalesced in areas of exudative retinal detachment, were evident. The patient presented meningismus with pleocytosis on cerebrospinal fluid analysis, and sensorineural deafness. Sympathetic ophthalmia was diagnosed. High-dose intravenous steroids followed by oral prednisone at a tapering dose and immunosuppressive agents (cyclosporine and azathioprine), topical steroids in both eyes and intravitreal steroids in the right eye were administered. Phacoemulsification and intraocular lens implantation were performed to treat a dense cataract of the right eye. After 24 months of follow-up, best-corrected visual acuity was 20/200 in the right eye and 20/25 in the left; no signs of intraocular inflammation were observed and neurological signs had resolved. Low maintenance doses of systemic steroids and immunosuppressive agents were administered up to month 18 of follow-up to avoid recurrence.

Conclusions

Sympathetic ophthalmia is a rare, but severe disease that can occur after resection of iridociliary melanoma. High-dose steroid therapy and supplementation with immunosuppressive agents early in the course of the disease was effective in resolving the condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chan CC, Roberge FG, Whitcup SM, Nussenblatt RB (1995) 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, from 1982 to 1992. Arch Ophthalmol 113:597–601

    PubMed  CAS  Google Scholar 

  2. Comer M, Taylor C, Chen S et al (2001) Sympathetic ophthalmia associated with high frequency deafness. Br J Ophthalmol 85:496

    Article  PubMed  CAS  Google Scholar 

  3. Conway RM, Chua WC-T,Qureshi C, Billson FA (2001) Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment. Br J Ophthalmol 85:848–854

    Article  PubMed  CAS  Google Scholar 

  4. Gasch AT, Foster CS, Grosskreutz CL, Pasquale LR (2000) Postoperative sympathetic ophthalmia. Int Ophthalmol Clin 40(1):69–84

    Article  PubMed  CAS  Google Scholar 

  5. Bilyk JR (2000) Enucleation, evisceration and sympathetic ophthalmia. Curr Opin Ophthalmol 11:372–385

    Article  PubMed  CAS  Google Scholar 

  6. Kawakami Y, Suzuki Y, Shofuda T et al (2000) T cell immune responses against melanoma and melanocytes in cancer and autoimmunity. Pigment Cell Res 13(Suppl 8):163–169

    Article  PubMed  Google Scholar 

  7. Kilmartin DJ, Dick AD, Forrester JV (2000) Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol 84:259–263

    Article  PubMed  CAS  Google Scholar 

  8. Kilmartin DJ, Dick AD, Forrester JV (2000) Sympathetic ophthalmia risk following vitrectomy:should we counsel patients? Br J Ophthalmol 84:448–449

    Article  PubMed  CAS  Google Scholar 

  9. Kilmartin DJ, Wilson D, Liversidge J et al (2001) Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol 85:281–286

    Article  PubMed  CAS  Google Scholar 

  10. Ramadan A, Nussenblatt RB (1996) Visual prognosis and sympathetic ophthalmia. Curr Opin Ophthalmol 7;III:39–45

    Article  Google Scholar 

  11. Read RW, Holland GN, Rao NA et al (2001) Revised diagnostic criteria for Vogt Koyanagi Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647–652

    Article  PubMed  CAS  Google Scholar 

  12. Vote BJ, Hall A, Cairns J, Buttery R (2004) Changing trends in sympathetic ophthalmia. Clin Exp Ophthalmol 32(5):542–545

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose Garcia-Arumi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia-Arumi, J., Montolio Gil, M., Morral Palau, M. et al. Sympathetic ophthalmia after surgical resection of iridociliary melanoma. A case report. Graefe's Arch Clin Exp Ophthalmo 244, 1353–1356 (2006). https://doi.org/10.1007/s00417-006-0299-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-006-0299-1

Keywords

Navigation